Last update Dec. 17, 2024
Limited compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Black Cohosh is also known as
Black Cohosh in other languages or writings:
Main tradenames from several countries containing Black Cohosh in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche, España of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Herbaceous plant native to eastern North America. Rhizomes and roots are used. It contains triterpene heterosides saponosides (acteine, deoxyacteine and others) and hydroxycinnamic acid derivatives. It is traditionally attributed estrogenic properties that have been scientifically denied (Ruhlen 2007, Liske 2002, WHO 2002). Indications Commission E of the German Ministry of Health: dysmenorrhea, premenstrual, menopause (Blumenthal 1998). It is also used without proven data in endometritis and to increase breast milk production. (Amer 2015, Dugoua 2006, McKenna 2001)
As of the last update we found no published data on its excretion in breast milk.
It may present moderate adverse effects (Posadzki 2013) and cases of severe acute hepatitis have been published. (Chitturi 2008)
It is a plant widely used as such and in dietary supplements. It has not been evaluated in quality clinical trials and there is little evidence to support the safety of its use, particularly during breastfeeding. (Amer 2015, Sachs 2013, Dugoua 2006)
Has components that, in vitro, can bind to the human estrogen receptor and behave as an endocrine disruptor (Powers 2015); according to some authors it could theoretically decrease milk production, so they do not recommend it during breastfeeding. (Amir 2011, WHO 2002)